We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Fully Immersive 3D AR Surgical Navigation System Demonstrates High Accuracy for EVD Placement

By HospiMedica International staff writers
Posted on 23 Jan 2023
Print article
Image: Skull phantom showing instruments after placement with VisAR (Photo courtesy of Novarad)
Image: Skull phantom showing instruments after placement with VisAR (Photo courtesy of Novarad)

External ventricular drain (EVD) is a common neurosurgical procedure, although it hasn't changed significantly in 100 years. Bedside ICU ventriculostomy is a common procedure that is fraught with error, and placement errors occur in about 40% of cases using the standard freehand technique. Now, an augmented reality surgical navigation system has demonstrated its potential to improve the accuracy of EVD placement.

Researchers evaluated VisAR, a low-cost navigation technology from Novarad Corporation (Provo, UT, USA) that uses an off-the-shelf Microsoft AR headset to revolutionize the delivery of neurosurgical care. With under two-minute setup time, image visible codes for instant registration, and a preoperative planning system allowing trajectory and target design, Novarad's VisAR system improves workflow while reducing costs compared to other navigation technologies.

For their study, the researchers constructed phantom models: a skull phantom model filled with ballistic gelatin and a phantom model simulating the ventricular structure. In addition, the ability of VisAR flattening the learning curve and improving the accuracy of surgeons of various levels of training was studied in a cadaver model. The measured accuracy was done using VisAR on both phantom and cadaver models. The researchers found that the efficacy of Novarad's VisAR augmented reality guidance system demonstrated an angular error of 1.3° (close to what can be achieved with a robot and below the 2° standard for stereotactic cranial navigation set by the FDA. This result is dramatically better than current standard of care freehand technique. The various experience levels of the participants did not impact their success, illustrating the potential of VisAR accelerating the training of physicians.

"VisAR provides the precision of a robot, the portability of a stethoscope, and the versatility of human-powered intelligence," said Dr. Wendell Gibby, Founder and CEO, Novarad.

"Overall, these accuracy results suggest that a surgeon placing an EVD with AR technology would be capable of millimeter accuracy, which could be especially helpful in cases with small or displaced ventricles," said Dr. Michael Karsy, Assistant Professor of Neurosurgery, Neurooncology, and Skull Base, University of Utah Health.

Related Links:
Novarad Corporation

Gold Supplier
Conductive Gel
High-Frequency X-Ray Generator
Battery X-Ray Generator
Electric Gynecological Operating Table
Patient Transfer Stretcher
TT-Patient Transfer Stretcher

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.